Ajmalicine (Raubasine) hydrochloride, a potent adrenolytic compound, selectively inhibits alpha1-adrenoceptors and acts as a reversible, non-competitive full inhibitor of nicotine receptors with an IC50 of 72.3 µM. This chemical also serves as an anti-hypertensive and exhibits sedative activity, making it useful in various therapeutic applications.